Tweenvest Stocks

Nuvo Pharmaceuticals Inc. (OTCPK: MRVF.F)

Health Care · Pharmaceuticals · CA

$

today · 1Y

Nuvo Pharmaceuticals Inc. (OTCPK: MRVF.F) operates in the Pharmaceuticals industry within the Health Care sector.

Tweenvest scores Nuvo Pharmaceuticals Inc. across four factors: quality 54/100, growth 49/100. Its strongest factor is quality.

MRVF.F price history

Not enough price history to draw a chart yet.

Key figures

Market cap
Revenue (TTM)
$52.74M
P/E
EPS
0.29
Dividend yield
Beta (5Y)
52-week high
$—
52-week low
$—
Avg volume (3M)
Shares outstanding
Employees
101
Next earnings

About Nuvo Pharmaceuticals Inc.

Nuvo Pharmaceuticals Inc., doing business as Miravo Healthcare, provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticaria; Cambia, a nonsteroidal anti-inflammatory drug for migraine; Suvexx/Treximet, a migraine medicine; NeoVisc, an injectable viscosupplement for osteoarthritis; and Resultz, FullMarks, and LAUSBUB for head lice infestations. The company also provides Bezalip SR for patients with high cholesterol or high levels of triglycerides; Proferrin, an iron supplement for the prevention and treatment of iron deficiency; Fiorinal 1 and Fiorinal C1 for the relief of tension-type headaches; Collatamp G for surgical implantation during surgery; PegaLAX, a laxative for the treatment of occasional constipation and irregularity; Mutaflor, a probiotic for the management and relief of chronic constipation and associated abdominal pain and cramps; MoviPrep for the cleansing of the colon in preparation for colonoscopy; and Soriatane to treat psoriasis and other keratinization disorders. In addition, it offers Pennsaid and Pennsaid 2% topical treatments for osteoarthritic pain; Vimovo for relief of arthritis symptoms; SYNERA and RAPYDAN topical patches used to help prevent pain associated with needle sticks and other superficial skin procedures; Yosprala for the prevention of heart attacks and strokes; and Heated Lidocaine/Tetracaine Patch, a topical patch applied prior to painful medical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was incorporated in 1983 and is headquartered in Mississauga, Canada.

ISIN
CA67092F1045
Founded
1983
Listed since
Feb 26, 1997
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
Eli Lilly and CompanyNYSE: LLY$1.12T$1,257.35+0.16%
Johnson & JohnsonNYSE: JNJ$651.25B$271.37+0.42%
Merck & Co., Inc.NYSE: MRK$376.37B$152.55+2.39%
Roche Holding AGSWX: ROP$373.91BCHF370.90-1.25%
Novartis AGSWX: NOVN$302.17BCHF127.42+0.85%
AstraZeneca PLCLSE: AZN$258.76B£121.48-0.76%
Novo Nordisk A/SCPSE: NOVO B$207.84BDkr300.85+1.59%
Pfizer Inc.NYSE: PFE$159.99B$28.15+0.29%

Browse every Pharmaceuticals company →

Figures last refreshed Aug 18, 2026.